What is the address of DOKTER INES SAMYN, MEDISCHE ONCOLOGIE?

The registered office of DOKTER INES SAMYN, MEDISCHE ONCOLOGIE is located at Roodhuisweg(Bel) 46, 8510 Kortrijk.

Is DOKTER INES SAMYN, MEDISCHE ONCOLOGIE still active?

Yes. According to the CBE (19 September 2026) DOKTER INES SAMYN, MEDISCHE ONCOLOGIE is active, legal situation “Normale toestand”, started on 2 December 2009.

Is DOKTER INES SAMYN, MEDISCHE ONCOLOGIE registered on Peppol?

No, DOKTER INES SAMYN, MEDISCHE ONCOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DOKTER INES SAMYN, MEDISCHE ONCOLOGIE?

The enterprise number of DOKTER INES SAMYN, MEDISCHE ONCOLOGIE is BE0821228328.

When was DOKTER INES SAMYN, MEDISCHE ONCOLOGIE founded?

DOKTER INES SAMYN, MEDISCHE ONCOLOGIE was founded on 2 December 2009.

Who are the directors of DOKTER INES SAMYN, MEDISCHE ONCOLOGIE?

According to the 2025 annual accounts, the directors of DOKTER INES SAMYN, MEDISCHE ONCOLOGIE are: Ines SAMYN.

Is DOKTER INES SAMYN, MEDISCHE ONCOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 December 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER INES SAMYN, MEDISCHE ONCOLOGIE make in 2025?

DOKTER INES SAMYN, MEDISCHE ONCOLOGIE posted a profit after taxes of € 138,896 in financial year 2025.

What is the revenue of DOKTER INES SAMYN, MEDISCHE ONCOLOGIE?

As a small company, DOKTER INES SAMYN, MEDISCHE ONCOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 197,285.

DOKTER INES SAMYN, MEDISCHE ONCOLOGIE (Private Limited)

Dossier DOKTER INES SAMYN, MEDISCHE ONCOLOGIE, printed on 19 September 2026 from databakkes.be/en/0821228328/dokter-ines-samyn-medische-oncologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DOKTER INES SAMYN, MEDISCHE ONCOLOGIE from Kortrijk, company number BE0821228328, closed financial year 2025 with a result of € 138,896 after tax. For that financial year DOKTER INES SAMYN, MEDISCHE ONCOLOGIE recorded a gross margin of € 197,285 and equity of € 801,934. Compared with financial year 2024, the result moved from € 136,795 to € 138,896. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Healthy

€ 801,934

▼ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 138,896

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 742,894

▲ 245% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 632,412 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 935

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 190,701 Gross margin 2022: € 190,701 First fiscal year in the series	€ 212,055 Gross margin 2023: € 212,055 ▲ 11% vs 2022 (€ 190,701) Favourable step	€ 205,921 Gross margin 2024: € 205,921 ▼ 3% vs 2023 (€ 212,055) Unfavourable step	€ 197,285 Gross margin 2025: € 197,285 ▼ 4% vs 2024 (€ 205,921) Unfavourable step	▼ 4%
Profit after taxes	€ 124,904 Profit after taxes 2022: € 124,904 First fiscal year in the series	€ 136,261 Profit after taxes 2023: € 136,261 ▲ 9% vs 2022 (€ 124,904) Favourable step	€ 136,795 Profit after taxes 2024: € 136,795 Unchanged (€ 136,261) Favourable step	€ 138,896 Profit after taxes 2025: € 138,896 ▲ 2% vs 2024 (€ 136,795) Favourable step	▲ 2%
Equity	€ 1,024,059 Equity 2022: € 1,024,059 First fiscal year in the series	€ 1,159,488 Equity 2023: € 1,159,488 ▲ 13% vs 2022 (€ 1,024,059) Favourable step	€ 1,295,450 Equity 2024: € 1,295,450 ▲ 12% vs 2023 (€ 1,159,488) Favourable step	€ 801,934 Equity 2025: € 801,934 ▼ 38% vs 2024 (€ 1,295,450) Unfavourable step	▼ 38%
Total debts	€ 300,213 Total debts 2022: € 300,213 First fiscal year in the series	€ 306,425 Total debts 2023: € 306,425 ▲ 2% vs 2022 (€ 300,213) Unfavourable step	€ 307,938 Total debts 2024: € 307,938 Unchanged (€ 306,425) Unfavourable step	€ 942,441 Total debts 2025: € 942,441 ▲ 206% vs 2024 (€ 307,938) Unfavourable step	▲ 206%
Cash	€ 945,453 Cash 2022: € 945,453 First fiscal year in the series	€ 1,094,024 Cash 2023: € 1,094,024 ▲ 16% vs 2022 (€ 945,453) Favourable step	€ 215,370 Cash 2024: € 215,370 ▼ 80% vs 2023 (€ 1,094,024) Unfavourable step	€ 742,894 Cash 2025: € 742,894 ▲ 245% vs 2024 (€ 215,370) Favourable step	▲ 245%
Retained profit	€ 1,011,659 Retained profit 2022: € 1,011,659 First fiscal year in the series	€ 1,147,088 Retained profit 2023: € 1,147,088 ▲ 13% vs 2022 (€ 1,011,659) Favourable step	€ 1,283,050 Retained profit 2024: € 1,283,050 ▲ 12% vs 2023 (€ 1,147,088) Favourable step	€ 789,534 Retained profit 2025: € 789,534 ▼ 38% vs 2024 (€ 1,283,050) Unfavourable step	▼ 38%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 833 Dividend 2024: € 833 Unchanged (€ 833) Unchanged	€ 632,412 Dividend 2025: € 632,412 ▲ € 631,579 vs 2024 (€ 833) Unchanged	▲ € 631,579
Balance sheet total	€ 1,324,272 Balance sheet total 2022: € 1,324,272 First fiscal year in the series	€ 1,465,913 Balance sheet total 2023: € 1,465,913 ▲ 11% vs 2022 (€ 1,324,272) Unchanged	€ 1,603,388 Balance sheet total 2024: € 1,603,388 ▲ 9% vs 2023 (€ 1,465,913) Unchanged	€ 1,744,376 Balance sheet total 2025: € 1,744,376 ▲ 9% vs 2024 (€ 1,603,388) Unchanged	▲ 9%

Key figures of DOKTER INES SAMYN, MEDISCHE ONCOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER INES SAMYN, MEDISCHE ONCOLOGIE?

What happened at DOKTER INES SAMYN, MEDISCHE ONCOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 138,896 (▲ 2% vs 2024). Source: NBB ↗
Dec 2, 2009 New establishment in Kortrijk. KBO
Dec 2, 2009 Start of the company according to the CBE. KBO

In short

From € 124,904 profit in 2022 to € 138,896 profit in 2025.

Paid € 229,030 in corporate taxes since 2022.

Best year ever: 2025, with € 138,896 profit.

Paid out € 634,878 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER INES SAMYN, MEDISCHE ONCOLOGIE? We notify you, reason included.

Follow DOKTER INES SAMYN, MEDISCHE ONCOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ines SAMYN

DOKTER INES SAMYN, MEDISCHE ONCOLOGIE

Behind DOKTER INES SAMYN, MEDISCHE ONCOLOGIE is Ines SAMYN.

See the full network in the app

Directors

According to the 2025 annual accounts

Ines SAMYN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Roodhuisweg(Bel) 46

8510 Kortrijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0821.228.328
VAT number: BE 0821.228.328
Registered office: Roodhuisweg(Bel) 46, 8510 Kortrijk
Names & denominations: DOKTER INES SAMYN, MEDISCHE ONCOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 December 2009
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗